Should adolescents be vaccinated against hepatitis A: The Hong Kong experience

Vaccine

Volumn 18, Issue 9-10, 1999, Pages 941-946

  Lee, A ^a   Cheng, F ^a   Lau, L ^a   Lo, A ^a   Fabb, W E ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adolescents; Hepatitis A; Immunisation; Sero epidemiology

Indexed keywords

HEPATITIS A VACCINE;

ADOLESCENT; AGE; ARTICLE; DRUG INDICATION; EDUCATION; FEMALE; HEPATITIS A; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SEROEPIDEMIOLOGY; SOCIAL STATUS; VACCINATION;

ADOLESCENT; ADULT; CHILD; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS ANTIBODIES; HONG KONG; HUMANS; IMMUNOGLOBULIN G; MALE; VIRAL HEPATITIS VACCINES;

EID: 0032751394     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00339-4     Document Type: Article

References (39)

1. Fitzner K.A. Hepatitis A vaccination: a cost-benefit study in Hong Kong. Hong Kong Practitioner. 16:(7):1994;357-366.
2. Steffen R., et al. Health problems after travel to developing countries. J. Infect. Dis. 156:1987;84-91.
3. Forbes A., William R. Increasing age: an important adverse prognostic factor in hepatitis A infection. J. R. Coll. Physicians London. 22:1988;237-239.
4. Hesketh LM, Rowlatt JA, Gay NJ, Morgan-Capner P, Miller E. Childhood infection with hepatitis A and B virus in England and Wales. Communicable Disease Report. CDR Review. 7(4): R60-3, 1997 Apr 4, Public Health Laboratory. Preston, UK.
5. Gay N.J., Morgan-Capner P., Wright J., Farrington C.P., Miller E. Age-specific antibody prevalence to hepatitis A in England: implications for disease control. Epidemiol. Infect. 113:1994;113-120.
6. Hsu H.Y., Chang M.H., Chen D.S., Lee C.Y., Sung J.L. Changing sero-epidemiology of hepatitis A virus infection in Taiwan. J. Med. Virol. 17:1985;297-301.
7. Tzen K.T., Chang M.H., Tsen Y.J., Lee C.Y., Chen D.S. Hepatitis A virus infections in Taipei City in 1989. J. Formosa Med. Association. 90:1991;138-140.
8. Ho Y.Y., Chan B.C.H. Does Hong Kong need hepatitis A vaccine? Hong Kong Med. J. 1:1995;137-139.
9. Ikematsu H., Kashiwagi S., Havashi J., Nomura H., Kajiyama W., Tani S., Uragari Y., Goto M. A sero-epidemiological study of hepatitis A virus infection: statistical analysis of two independent cross sectional surveys in Okinawa, Japan. Am. J. Epidemiol. 126:1987;50-54.
10. Frosner G.G., Papaevangelou G., Butler R., Iwarson S., Lindholm A., Courouce-Pauty A., Hass H., Deinhardt F. Antibodies against hepatitis A in seven European countries, I: comparison of prevalence data in different age groups. Am. J. Epidemiol. 110:1979;63-69.
11. Hay J. Health care in Hong Kong. Chinese University Press, 1992. Chap 1, p10-11.
12. Lemon S.M. Type A viral hepatitis: new development in an old disease. N. Eng. J. Med. 313:1985;1059-1067.
13. Scientific Working Group on Viral Hepatitis Prevention. Surveillance of Viral Hepatitis in Hong Kong. A report. Department of Health, 1996.
14. Yao G. Clinical spectrum and natural history of viral hepatitis A in a 1988 Shanghai epidemic. Viral Hepatitis and Liver Disease. 1991;76-78 William & Wilkins, Baltimore.
15. Kane M.A., Clements J., Hu D. Hepatitis B. Jamison D.T., Mosley W.H., Measham A.R., Bobadilla J. Disease control priorities in developing countries. 1993;321-330 Oxford University Press, New York.
16. Siegl G., Lemon S.M. Recent advances in hepatitis A vaccine development. Virus Res. 17:1990;75-92.
17. Ulf Westblom T., et al. Safety and immunogenicity of an inactivated hepatitis A vaccine: effect of dose and vaccination schedule. J. Infect. Dis. 169:1994;996-1001.
18. Lee S.D., et al. Immunogenicity of inactivated hepatitis A vaccine in children. Gastreenterology. 104:1993;1129-1132.
19. Melnick J.L. History and epidemiology of hepatitis A virus. J. Infect. Dis. 171:(Suppl. 1):1995;S2-S8.
20. 1996 Population By-census: Summary Results. Census and Statistics Department Hong Kong.
21. Hepatitis: IMx System: HAVAB. Abbot Laboratories, USA July, 1994.
22. Statistical Package for Social Science. SPSS Inc, Chicago USA Nov 1996.
23. Yap I., Guan R. Hepatitis A sero-epidemiology in Singapore: a changing pattern. Trans. R. Soc. Trop. Med. Hyg. 87:1993;22-23.
24. Akbar S.M., Onj M., Kanaoka, et al. The sero-epidemiology of hepatitis A and B in Japanese town. Asia Pac. J. Public Health. 6:(2):1992;26-29.
25. Fock K.M., Tay H.H., Phua K.B., Guan, et al. Sero-prevalence of antibodies against hepatitis A in Singapore: the NFDP experience. Singapore Med. J. 36:(1):1995;26-27.
26. Snapiro C.N., Coleman P.J., McQuillan G.M., Alter M.J., Margolis H.S. Epidemiology of hepatitis A: sero-epidemiology and risk groups in the CPSA. Vaccine. 10:(sapp11):1992;559-562.
27. Regan C.M., et al. Hepatitis vaccine. Br. Med. J. 303:1991;414.
28. Chin K.P., Lok A.S., Wong L.S., et al. Current sero-epidemiology of hepatitis A in Hong Kong. J. Med. Virol. 34:1991;191-193.
29. Liu C.C., Wang J.Y., Yan W.J. Sero-epidemiology in Southern Taiwan. Acta Paed. Sin. 35:1994;393-398.
30. Wang L.Y., Chen Y.W., Chou S.J., et al. Secular trend and geographic variation in hepatitis A infection and hepatitis B carrier rate amongst adolescents in Taiwan: an island-wide survey. J. Med. Viral. 39:1993;1-5.
31. Poovorawan Y., Paiboonkasemsuthi S., Theamboonler S.A., et al. Sero-epidemiology of antibody to hepatitis A in the rural eastern part of Thailand. Southeast Asia J. Trop. Med. Public Health. 22:1991;35-38.
32. Chang H.C., Wu S.M., Pu C.C., Yuan R. Epidemiologic and clinical studies on 3084 cases of hepatitis A in Shanghai. Chinese J. Clin. Hepatol. 5:1989;201-203.
33. Steffen R. Hepatitis A in traveller: the European experience. J. Infect. Dis. 171:(Suppl 1):1995;S2-S8.
34. Wolfe M.S. Hepatitis A and the American traveller. J. Infect. Dis. 171:(Suppl 1):1995;S29-S32.
35. Hofmann F., et al. Hepatitis A as an occupational hazard. Vaccine. 10:(Suppl 1):1992;S82-S84.
36. Mao J.S., Dong D.X., Zhang H.Y., et al. Primary study of attenuated live hepatitis A vaccine (H2 strain) in humans. J. Infect. Dis. 159:1989;621-624.
37. Burke D.S., Snitbhan R., Johnson D.E., Scott R.M. Age-specific prevalence of hepatitis A virus antibody in Thailand. Am. J. Epidemiol. 113:1981;245-249.
38. Innis B.L., Snitbhan R., Hoke C.H., Munindhorn W., Laorakpongse T. The declining transmission of hepatitis A in Thailand. J. Infect. Dis. 163:1991;989-995.
39. Bader T.F. Hepatitis A vaccine. Am. J. Gastroenterol. 91:(2):1996;217-222.